Skip to main content
. 2022 May 9;9:196. doi: 10.1038/s41597-022-01264-y

Fig. 2.

Fig. 2

Summary of sample-platform overlap in (a) The TACERA cohort, (b) The Vaccine Cohort. Vaccine V1-V8 relates to visits 1, 2, 4, 6 & 8 at day -7, 0, 3, 56, 63.